Contact this trialFirst, we need to learn more about you.
Anti-fibrotic agent
AP01 for Pulmonary Fibrosis
Recruiting0 awardsPhase 2
Winter Park, Florida
This trial will test whether a new drug, AP01, is safe and effective in treating a specific condition when added to standard treatment. Participants will receive either AP01 or a placebo for 52 weeks
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.